The RbM Consortium: 10 Burning Questions about Risk-Based Study Management

By |2016-11-16T18:35:47+00:00January 14, 2015|White Paper|2 Comments

Moe Alsumidaie, María Proupín-Pérez, PhD, Artem Andrianov, PhD, Beat Widler, PhD, Peter Schiemann, PhD, Johanna Schenk, MD, PhD Originally published on Applied Clinical Trials [link to the article]. Quality Risk Management (QRM), Quality by Design (QbD), Risk-based Monitoring (RbM), data driven monitoring or centralized monitoring [...]